KEEP FOLLOWING THE STORY
JNJ news & interviews.
Johnson & Johnson Reports Q2 2026 Results and Raises Outlook
Read the original announcement and examine the details behind the headline.
Read the story
YOUTUBE INTERVIEWWatch Jim Cramer's interview with Johnson & Johnson CEO Joaquin Duato
In conversation with Joaquin Duato, Johnson & Johnson CEO at the time of the interview.
Watch on YouTubeLinks checked Sep 23, 2026. Company news is published by the company; interviews reflect the recording date and may feature former leaders. These are selected links, not a live news feed.
The stories on our desk.
No company announcement is currently covered in our curated story library. Explore the official filings below.
Who’s behind the business?

Joaquin Duato
Chairman and Chief Executive Officer
Sources & date
Role checked 2026-09-23. Photo: Johnson & Johnson. Inclusion does not imply endorsement.
Review the leadership biography alongside the annual report, compensation disclosures and governance materials. Social posts are not a substitute for filings.
The business, in a sentence.
Innovative medicines and medical technology.
The question to investigate.
How do the pharmaceutical and medical-technology portfolios balance product concentration, innovation and cash generation?
Risks to examine.
Review competitive pressure, valuation expectations, execution, regulation, financing and exposure to the economic cycle. These are research topics, not an exhaustive assessment.
Build a dated research record
0 / 5 reviewedShared business exposures
These connections use editorial theme tags. They are not measured return correlations, supplier confirmations or trade recommendations.

